Announcing the TCT 2018 Press Conference Schedule
NEW YORK – September 4, 2018 – The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and late-breaking clinical science that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. TCT, the world's premier educational meeting specializing in interventional cardiovascular medicine, will take place September 21-25 in San Diego, California.
Late-breaking trials and clinical science will be presented in the Main Arena and highlighted during press conferences scheduled for Saturday, September 22; Sunday, September 23; Monday, September 24; and Tuesday, September 25.
The complete agenda for TCT 2018 is also available online. Browse through a wide array of topics and learn more about individual sessions, presentations, and faculty on the TCT Web site.
Media are invited to attend TCT. If you are unable to attend in person, you may still cover it remotely via Virtual TCT. Registering as media ensures that you have access to all the press conferences, trial data, abstracts, and press releases. More information on press credentials and guidelines can be found at http://www.crf.org/tct/press/press-credentials-and-guidelines. To apply for press credentials, visit: http://www.crf.org/tct/press/press-registration-form.
Receive updates on Twitter at http://twitter.com/TCTConference and http://twitter.com/crfheart.
Saturday, September 22, 2018
7:30 AM – 9:00 AM
Moderator: Roxana Mehran, MD Discussants: David J. Cohen, MD, MSc; Antonio Colombo, MD; Michael R. Jaff, DO; Sahil A. Parikh, MD; Sunil V. Rao, MD
IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions William A. Gray, MD
BIONYX: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population Clemens von Birgelen, MD, PhD
ReCre8: A Randomized Trial Evaluating a Polymer-Free Coronary Drug-Eluting Stent in an All-Comers Patient Population Pieter R. Stella, MD, PhD
LEADERS FREE II: Evaluation of a Polymer-Free Coronary Drug-Eluting Stent in High Bleeding-Risk Patients With One-Month Dual Antiplatelet Therapy Mitchell W. Krucoff, MD
TALENT: A Randomized Trial Evaluating an Ultra-Thin Strut Bioresorbable Polymer-Based Coronary Drug-Eluting Stent in an All-Comers Patient Population Patrick W. Serruys, MD, PhD
SORT OUT IX: A Randomized Trial Comparing a Polymer-Free Coronary Drug-Eluting Stent With an Ultra-Thin Strut Bioresorbable Polymer-Based Drug-Eluting Stent in an All-Comers Patient Population Lisette Okkels Jensen, MD, DMSci, PhD
Sunday, September 23, 2018
7:30 AM – 9:15 AM
Moderator: Ori Ben-Yehuda, MD
Discussants: Mayra Guerrero, MD; Martin B. Leon, MD; Michael J. Mack, MD; Jeffrey J. Popma, MD; Molly Szerlip, MD
COAPT: A Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients With Heart Failure and Secondary Mitral Regurgitation Gregg W. Stone, MD
REDUCE-FMR: A Sham-Controlled Randomized Trial of Transcatheter Mitral Valve Indirect Annuloplasty in Patients With Heart Failure and Secondary Mitral Regurgitation Horst Sievert, MD
SOLVE-TAVI: A 2×2 Randomized Trial of Self-Expandable vs Balloon-Expandable Valves and General vs Local Anesthesia in Patients Undergoing Transcatheter Aortic Valve Implantation Holger Thiele, MD
PADN-5: A Randomized Trial of Pulmonary Artery Denervation in Patients With Combined Pre- and Postcapillary Pulmonary Hypertension Shao-Liang Chen, MD
PARTNER VALVE-IN-VALVE: Late Follow-up After Treatment of Failing Surgical Aortic Bioprosthetic Valves With a Balloon-Expandable Transcatheter Heart Valve John G. Webb, MD
Prosthesis-Patient Mismatch: Incidence, Predictors, and Outcome of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement Howard C. Herrmann, MD
TRIVALVE: Evaluation of Edge-to-Edge Valve Repair for Symptomatic Tricuspid Regurgitation Jörg Hausleiter, MD
Monday, September 24, 2018
7:30 AM – 9:15 AM
Moderator: Juan F. Granada, MD
Discussants: C. Michael Gibson, MS, MD; Morton J. Kern, MD; Akiko Maehara, MD; Mark Reisman, MD
FAST-FFR: Accuracy of Fractional Flow Reserve Derived From Coronary Angiography William F. Fearon, MD
LRP: Assessment of Coronary Near-Infrared Spectroscopy Imaging to Detect Vulnerable Plaques and Vulnerable Patients Ron Waksman, MD
OAC ALONE: A Randomized Trial of Oral Anticoagulation With vs Without Single Antiplatelet Therapy in Patients With Atrial Fibrillation Beyond One Year After Drug-Eluting Stent Implantation Yukiko Nakano, MD, PhD
ULTIMATE: A Randomized Trial of Intravascular Ultrasound Guidance of Coronary Drug-Eluting Stent Implantation in an All-Comers Patient Population Junjie Zhang, MD
SYNTAXES: Ten-Year Follow-up From a Randomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main and Triple Vessel Disease Daniel J.F.M. Thuijs, MD, PhD
MAIN-COMPARE: Ten-Year Follow-up From a Nonrandomized Trial of Drug-Eluting Stents vs Bypass Surgery in Patients With Left Main Disease Seung-Jung Park, MD, PhD
PREPARE-CALC: A Randomized Trial of High-speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions Gert Richardt, MD, PhD
Tuesday, September 25, 2018
7:30 AM – 9:15 AM
Moderator: Ajay J. Kirtane, MD, SM
Discussants: Deepak L. Bhatt, MD, MPH; George D. Dangas, MD, PhD; Cindy L. Grines, MD; Felix Mahfoud, MD; Renu Virmani, MD
ABSORB IV: A Blinded Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in an Expanded Patient Population Using Optimized Technique Gregg W. Stone, MD
COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions Pieter C. Smits, MD, PhD
RADIOSOUND-HTN: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension Philipp Lurz, MD, PhD
CorMicA: A Randomized Trial of Invasive Coronary Function Testing in Patients With Angina and Nonobstructive Coronary Artery Disease Tom J. Ford, MBChB
RESET: Seven-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs Everolimus-Eluting Stents in Patients With Coronary Artery Disease Hiroki Shiomi, MD, PhD
NEOPRO: Nonrandomized Comparison of Two Transcatheter Heart Valve in Patients With Severe Aortic Stenosis Azeem Latib, MB, BCh
PORTICO I: One-Year Outcomes With a Self-Expanding, Repositionable Transcatheter Heart Valve in Patients With Severe Aortic Stenosis Lars Søndergaard, MD, DMSc
About CRF and TCT
The Cardiovascular Research Foundation (CRF) is a nonprofit research and educational organization dedicated to helping doctors improve survival and quality of life for people suffering from heart and vascular disease. For over 25 years, CRF has helped pioneer innovations in interventional cardiology and educated doctors on the latest treatments for heart disease.
Transcatheter Cardiovascular Therapeutics (TCT) is the annual scientific symposium of CRF and the world's premier educational meeting specializing in interventional cardiovascular medicine. Now in its 30th year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the world to present and discuss the latest evidence-based research in the field.
For more information, visit http://www.crf.org and http://www.tctconference.com.